Sign In
Buy ARAY
$0.370
-0.0286 (-7.18%)
At Close: Jun 03, 2026
Accuray Incorporated Reports Inducement Award Under NASDAQ Listing Rules
04:10pm, Friday, 29'th May 2026
MADISON, Wis., May 29, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported, as required by NASDAQ Listing Rules, equity inducement awards to Paul Miele, the company's new Chief Com
MADISON, Wis., May 15, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) and the University of Wisconsin School of Medicine and Public Health (UW SMPH) announced a new 10‑year strategic coll
Accuray Incorporated (ARAY) Q3 2026 Earnings Call Transcript
04:41am, Thursday, 07'th May 2026
Accuray Incorporated (ARAY) Q3 2026 Earnings Call Transcript
Accuray Reports Fiscal 2026 Third Quarter Financial Results
04:05pm, Wednesday, 06'th May 2026
MADISON, Wis., May 6, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the third quarter ended March 31, 2026.
Accuray to Report Third Quarter Fiscal 2026 Financial Results on May 6, 2026
04:05pm, Wednesday, 22'nd Apr 2026
MADISON, Wis., April 22, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the third quarter of fiscal year 2026, ended March 31, 2026, during a conference cal
Accuray (ARAY) to Release Quarterly Earnings on Wednesday
04:40am, Wednesday, 22'nd Apr 2026
Accuray (NASDAQ: ARAY - Get Free Report) is anticipated to issue its Q3 2026 results after the market closes on Wednesday, April 29th. Analysts expect the company to announce earnings of ($0.05) per s
Accuray Appoints Paul Miele as Senior Vice President and Chief Commercial Officer
09:00am, Monday, 06'th Apr 2026
MADISON, Wis., April 6, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY), a leading provider of radiation therapy systems for cancer treatment, today announced the appointment of Paul Miele a
Short Interest in Accuray Incorporated (NASDAQ:ARAY) Expands By 20.6%
04:49am, Thursday, 02'nd Apr 2026
Accuray Incorporated (NASDAQ: ARAY - Get Free Report) was the target of a significant growth in short interest in the month of March. As of March 13th, there was short interest totaling 6,598,752 shar
Accuray Q2 Earnings Call Highlights
04:26am, Friday, 06'th Feb 2026
Accuray (NASDAQ: ARAY) executives used the company's fiscal second-quarter earnings call to outline progress on a broad transformation program while acknowledging that tariff impacts and geopolitical
Accuray Incorporated (ARAY) Q2 2026 Earnings Call Transcript
06:10pm, Wednesday, 04'th Feb 2026
Accuray Incorporated (ARAY) Q2 2026 Earnings Call Transcript
Accuray Reports Fiscal 2026 Second Quarter Financial Results
04:05pm, Wednesday, 04'th Feb 2026
MADISON, Wis., Feb. 4, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the second quarter ended December 31, 2025.
Acuitas Investments LLC Raises Stake in Accuray Incorporated $ARAY
03:02am, Friday, 30'th Jan 2026
Acuitas Investments LLC increased its position in shares of Accuray Incorporated (NASDAQ: ARAY) by 67.7% during the third quarter, according to the company in its most recent Form 13F filing with the
Accuray to Report Second Quarter Fiscal 2026 Financial Results on February 4, 2026
04:05pm, Wednesday, 21'st Jan 2026
MADISON, Wis., Jan. 21, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the second quarter of fiscal year 2026, ended December 31, 2025, during a conference
Accuray (NASDAQ:ARAY) & Check-Cap (NASDAQ:CHEK) Critical Analysis
01:58am, Saturday, 03'rd Jan 2026
Check-Cap (NASDAQ: CHEK - Get Free Report) and Accuray (NASDAQ: ARAY - Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses
Radiation Therapy-Focused Accuray Details Workforce Reduction, Outsourcing In Major Transformation Push
12:27pm, Tuesday, 16'th Dec 2025
Accuray Incorporated (NASDAQ: ARAY) announced the first phase of a broad strategic, operational and organizational transformation designed to tighten cost controls, clarify accountability and accelera
